Factors Associated With PrEP Utilization and Access in the United States
Related Posts
Fujimoto GR, Wooley DP, Byers KB, Yang OO, Behrman AJ, Winters TH, Hudson TW. Response to the Letter to the Editor on Laboratory Monitoring After[...]
Marcus JL, Weddle A, Kelley CF, Agwu A, Montalvo S, Sherman E, Vijayan T, Gutierrez J, Hickey MD, Dilworth SE, Krakower D, Davis TL, Collins[...]
Blair CS, Cambou MC, Landovitz RJ. Update on HIV Chemoprevention. Annu Rev Med. 2025 Jan;76(1):43-56. doi: 10.1146/annurev-med-042823-013707. PMID: 39869431.